Rigel Pharmaceuticals (STU:RI2A) Change In Inventory : €0.7 Mil (TTM As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Rigel Pharmaceuticals Change In Inventory?

Rigel Pharmaceuticals's change in inventory for the quarter that ended in Mar. 2024 was €-2.1 Mil. It means Rigel Pharmaceuticals's inventory increased by €2.1 Mil from Dec. 2023 to Mar. 2024 .

Rigel Pharmaceuticals's change in inventory for the fiscal year that ended in Dec. 2023 was €1.1 Mil. It means Rigel Pharmaceuticals's inventory declined by €1.1 Mil from Dec. 2022 to Dec. 2023 .

Rigel Pharmaceuticals's Total Inventories for the quarter that ended in Mar. 2024 was €6.1 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Rigel Pharmaceuticals's Days Inventory for the quarter that ended in Mar. 2024 was 272.26.

Inventory Turnover measures how fast the company turns over its inventory within a year. Rigel Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.34.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Rigel Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.20.

Rigel Pharmaceuticals Change In Inventory Historical Data

The historical data trend for Rigel Pharmaceuticals's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rigel Pharmaceuticals Change In Inventory Chart

Rigel Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-0.33

-0.10

-4.31

-2.24

1.08

Rigel Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial															-1.82	0.29	0.26	2.32	-2.13

Rigel Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.7 Mil.

Rigel Pharmaceuticals (STU:RI2A) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Rigel Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	5.5585	/	1.863	*	365 / 4
	=	272.26

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Rigel Pharmaceuticals's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	1.863	/	5.5585
	=	0.34

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Rigel Pharmaceuticals's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	5.5585	/	27.171
	=	0.20

Rigel Pharmaceuticals Change In Inventory Related Terms

Thank you for viewing the detailed overview of Rigel Pharmaceuticals's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Rigel Pharmaceuticals (STU:RI2A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rigel Pharmaceuticals Inc (STU:RI2A) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

RIGL:USA

Address

611 Gateway Boulevard, Suite 900, South San Francisco, CA, USA, 94080

Website

https://www.rigel.com

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's lead drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility to develop and market the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

Rigel Pharmaceuticals (STU:RI2A) Headlines

No Headlines